These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18800188)

  • 41. Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells.
    Wei SQ; Sui LH; Zheng JH; Zhang GM; Kao YL
    Chin Med Sci J; 2004 Jun; 19(2):125-9. PubMed ID: 15250250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death.
    Kim SM; Park JH; Chung SK; Kim JY; Hwang HY; Chung KC; Jo I; Park SI; Nam JH
    J Virol; 2004 Dec; 78(24):13479-88. PubMed ID: 15564459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells.
    Sui Y; Yang Y; Wang J; Li Y; Ma H; Cai H; Liu X; Zhang Y; Wang S; Li Z; Zhang X; Wang J; Liu R; Yan Y; Xue C; Shi X; Tan L; Ren J
    Biomed Res Int; 2015; 2015():598386. PubMed ID: 26366416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
    You JJ; Yang CH; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells.
    Lee YJ; Lee DM; Lee SH
    Food Chem Toxicol; 2013 Aug; 58():169-76. PubMed ID: 23623839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
    Xie Q; Su J; Jiao B; Shen L; Ma L; Qu X; Yu C; Jiang X; Xu Y; Sun L
    Int J Oncol; 2016 Dec; 49(6):2507-2519. PubMed ID: 27748803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
    Mohanty S; Huang J; Basu A
    Clin Cancer Res; 2005 Sep; 11(18):6730-7. PubMed ID: 16166454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system.
    Martinerie C; Viegas-Pequignot E; Nguyen VC; Perbal B
    Mol Pathol; 1997 Dec; 50(6):310-6. PubMed ID: 9536281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression.
    Chen C; Ge C; Liu Z; Li L; Zhao F; Tian H; Chen T; Li H; Yao M; Li J
    J Exp Clin Cancer Res; 2018 Oct; 37(1):263. PubMed ID: 30376856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
    Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
    Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
    Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
    Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wortmannin enhances cisplatin-induced apoptosis in human ovarian cancer cells in vitro.
    Zhao JX; Liu H; Lv J; Yang XJ
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2428-34. PubMed ID: 25268086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein.
    Sasaki H; Kotsuji F; Tsang BK
    Gynecol Oncol; 2002 May; 85(2):339-50. PubMed ID: 11972398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyr61 Expression Pattern and Association with Clinicopathological Factors in Patients with Cervical Cancer.
    Mayer S; Gabriel B; Erbes T; Timme-Bronsert S; Jäger M; Rücker G; Kuf F; Bouda J; Bartakova A; Hausen AZ; Stickeler E; Gitsch G; Hirschfeld M
    Anticancer Res; 2017 May; 37(5):2451-2456. PubMed ID: 28476813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expressions of Cyr61 and WISP-3 in non-small cell lung cancer and its clinical significance].
    LV J; ZOU Y; ZHANG C; MAO Z
    Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1122-6. PubMed ID: 21159247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyr61 is a potential prognostic marker for prostate cancer.
    Terada N; Kulkarni P; Getzenberg RH
    Asian J Androl; 2012 May; 14(3):405-8. PubMed ID: 22343491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study.
    Ačkar L; Casjens S; Andreas A; Raiko I; Brüning T; Geffken M; Peine S; Kollmeier J; Johnen G; Bartkowiak K; Weber DG; Pantel K
    Mol Oncol; 2021 Nov; 15(11):2877-2890. PubMed ID: 34510714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.